Why these 4 ASX shares have started the week with a bang

The GetSwift Ltd (ASX:GSW) share price is one of four starting the week with a bang. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is on course to have a positive start to the week. At the time of writing the benchmark index is up 0.1% to 5,686 points.

Four shares which have started the week with strong gains are listed below. Here's why they are higher:

The Bubs Australia Ltd (ASX: BUB) share price is up 4% to 54 cents despite there being no news out of the infant formula company. While I saw value in its shares when they drifted down to 45 cents, I feel now they have rallied to 54 cents they ought to be classed as a hold.

The GetSwift Ltd (ASX: GSW) share price appears to have shaken off the profit takers and has climbed 8% to $2.15. The logistic platform provider's shares have more than doubled in value in less than a month thanks to a game-changing contract with US-giant NA Williams. Despite the strong gain, I still believe GetSwift is a great buy and hold investment option.

The Mayne Pharma Group Ltd (ASX: MYX) share price has rebounded from last week's drop with a 3% rise to 67.5 cents. The pharmaceutical company's shares fell 11% last week as concerns over competitive pressures in the U.S. generic drugs market weighed heavily on its shares.

The Mesoblast limited (ASX: MSB) share price has climbed almost 4% to $1.39 after the innovative cell-based medicines developer advised that its will present corporate updates at two healthcare conferences in New York this week. The focus will be on the Phase 3 clinical trials of its lead product candidates in acute graft versus host disease, chronic low back pain due to disc degeneration, and chronic heart failure.

Motley Fool contributor James Mickleboro owns shares of GetSwift Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »